赵利芹
Lv1
70 积分
2022-11-08 加入
-
Mutations in Acetylcholinesterase2 (ace2) increase the insensitivity of acetylcholinesterase to fosthiazate in the root-knot nematode Meloidogyne incognita
8个月前
已完结
-
SBRT for oligoprogressive disease: using the evidence to maximise the benefits
8个月前
已完结
-
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study
8个月前
已完结
-
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer
9个月前
已完结
-
Hughes R Initial SRS for Patients With 5 to 15 Brain Metastases: Results of a Multi-Institutional Experience[J]. International journal of radiation oncology, biology, physics, 2019, 104(5): 1091-1098
9个月前
已关闭
-
Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
1年前
已完结
-
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
1年前
已完结
-
Comparison of Pathologic Response and Survival Outcomes between Neoadjuvant Immunochemotherapy (nICT) and Neoadjuvant Chemoradiotherapy (nCRT) in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis
1年前
已完结
-
Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: A randomized double‐blind placebo‐controlled clinical trial
1年前
已完结
-
The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized, double‐blind, placebo‐controlled clinical trial
1年前
已完结